211 related articles for article (PubMed ID: 22432845)
1. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
[TBL] [Abstract][Full Text] [Related]
2. Oral locally active steroids in inflammatory bowel disease.
Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
[TBL] [Abstract][Full Text] [Related]
3. The safety of beclomethasone dipropionate in the treatment of ulcerative colitis.
Rizzello F; Mazza M; Salice M; Calabrese C; Calafiore A; Campieri M; Gionchetti P
Expert Opin Drug Saf; 2018 Sep; 17(9):963-969. PubMed ID: 30101623
[TBL] [Abstract][Full Text] [Related]
4. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
Campieri M
Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332
[TBL] [Abstract][Full Text] [Related]
5. Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial.
Prantera C; Rizzi M; Cottone M; Casa A; Annese V; Sturniolo GC; Marconi S; Lochs H
Dig Liver Dis; 2011 Jun; 43(6):459-64. PubMed ID: 21215714
[TBL] [Abstract][Full Text] [Related]
6. Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
Cross RK
Inflamm Bowel Dis; 2017 Oct; 23(10):1689-1701. PubMed ID: 28906290
[TBL] [Abstract][Full Text] [Related]
7. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
[TBL] [Abstract][Full Text] [Related]
8. Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis.
Salice M; Rizzello F; Calabrese C; Privitera Hrustemovic H; Gionchetti P
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):607-613. PubMed ID: 31106602
[No Abstract] [Full Text] [Related]
9. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?
De Cassan C; Fiorino G; Danese S
Dig Dis; 2012; 30(4):368-75. PubMed ID: 22796798
[TBL] [Abstract][Full Text] [Related]
10. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
[TBL] [Abstract][Full Text] [Related]
11. Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?
Saibeni S; Meucci G; Papi C; Manes G; Fascì-Spurio F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):949-62. PubMed ID: 24882015
[TBL] [Abstract][Full Text] [Related]
12. [Steroids in inflammatory bowel disease].
López San Román A; Garrido E
Rev Esp Enferm Dig; 2015 Sep; 107(9):573. PubMed ID: 26334467
[No Abstract] [Full Text] [Related]
13. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study.
Tursi A; Giorgetti GM; Brandimarte G; Elisei W; Aiello F
Med Sci Monit; 2006 Jun; 12(6):PI29-32. PubMed ID: 16733496
[TBL] [Abstract][Full Text] [Related]
14. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
Rutgeerts P
Mediators Inflamm; 1998; 7(3):137-40. PubMed ID: 9705597
[TBL] [Abstract][Full Text] [Related]
15. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
[TBL] [Abstract][Full Text] [Related]
16. Budesonide: teaching an old dog new tricks for inflammatory bowel disease treatment.
Angelucci E; Malesci A; Danese S
Curr Med Chem; 2008; 15(24):2527-35. PubMed ID: 18855676
[TBL] [Abstract][Full Text] [Related]
17. Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates.
Papi C; Aratari A; Moretti A; Mangone M; Margagnoni G; Koch M; Capurso L
Dig Dis Sci; 2010 Jul; 55(7):2002-7. PubMed ID: 19937467
[TBL] [Abstract][Full Text] [Related]
18. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy of inflammatory bowel disease.
Sack DM; Peppercorn MA
Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
[TBL] [Abstract][Full Text] [Related]
20. Oral beclomethasone: a review of its use in inflammatory bowel disease.
Danese S; Angelucci E; Marconi S; Repici A; Malesci A
Mini Rev Med Chem; 2008 Dec; 8(14):1459-63. PubMed ID: 19075804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
